ClinicalTrialsFinder
RecruitingNCT03209791

Ethanol Induces Skeletal Muscle Autophagy

Mechanisms of Skeletal Muscle Proteolysis With Ethanol Consumption: an Integrated Molecular Metabolic Approach

Sponsor

The Cleveland Clinic

Enrollment

40 participants

Start Date

May 18, 2015

Study Type

OBSERVATIONAL

Conditions

Alcoholic Liver Disease

Summary

In this study we plan to demonstrate that ethanol induces skeletal muscle autophagy to degrade MAA adducts.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Biopsies for people with alcoholic liver disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiopsies

Biopsy will be done on the Vastus Lateralis muscle in all groups

Locations(1)

Cleveland Clinic

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03209791

Related Trials

Study of Alcohol-related Liver Disease in Europe

NCT044006041 location

Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease

NCT041065189 locations

Intra-Hepatic Microbiota in Alcoholic Hepatitis

NCT063079641 location

Integrated Diagnostics for Early Diagnosis of Liver Disease

NCT046664021 location

Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19

NCT048584121 location